Neurobiology of Aging
Volume 30, Issue 7 , Pages 1052-1060 , July 2009

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease

  • Doris Culpan

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 117 970 1212x3068; fax: +44 117 957 3955.
    • ,
  • Dougal Cram

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Kate Chalmers

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Abigail Cornish

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Laura Palmer

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Jennifer Palmer

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Anthony Hughes

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Peter Passmore

      Affiliations

    • Department of Geriatric Medicine, Queen's University, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom
    • ,
  • David Craigs

      Affiliations

    • Department of Geriatric Medicine, Queen's University, 97 Lisburn Road, Belfast BT9 7BL, United Kingdom
    • ,
  • Gordon K. Wilcock

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Patrick G. Kehoe

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom
    • ,
  • Seth Love

      Affiliations

    • Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, John James Buildings, Frenchay Hospital, Frenchay, Bristol BS16 1LE, United Kingdom

Received 23 May 2007 ,Revised 10 October 2007 ,Accepted 22 October 2007.

References 

  1. Abdi H. Bonferroni and Sidak Corrections for Multiple Comparisons. Thousand Oaks, CA: Sage; 2007;
  2. Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and death. Genes Dev. 1998;12:2821–2830
  3. Babu JR, Geetha T, Wooten MW. Sequestosome  1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J. Neurochem. 2005;94:192–203
  4. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 2003;12:23–32
  5. Brown KD, Hostager BS, Bishop GA. Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 2002;277:19433–19438
  6. Conne B, Stutz A, Vassalli J-D. The 3[prime] untranslated region of messenger RNA: a molecular/‘hotspot/’ for pathology?. Nat. Med. 2000;6:637
  7. Culpan D, Matthews S, MacGowan SH, Love S, Wilcock GK. The expression of the anti-inflammatory cytokine IL-10 in Alzheimer's disease is independant of IL-10 promoter polymorphisms. Neurobiol. Aging. 2002;23:S311
  8. Culpan D, Cornish A, Kehoe PG, Love S, Wilcock GK. P3-203 TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease. Neurobiol. Aging. 2004;25:S413
  9. Duckett CS, Thompson CB. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 1997;11:2810–2821
  10. Emahazion T, Feuk L, Jobs M, Sawyer SL, Fredman D, St Clair D, et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 2001;17:407
  11. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, et al. Increased efficiency of mRNA 3[prime] end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat. Genet. 2001;28:389
  12. Hsu H, Shu H-B, Pan M-G, Goeddel DV. TRADD–TRAF2 and TRADD–FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84:299
  13. Inoue J-I, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, et al. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 2000;254:14
  14. Kim WJ, Back SH, Kim V, Ryu I, Jang SK. Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol. Cell Biol. 2005;25:2450–2462
  15. Lee EK, Park YW, Shin DY, Mook-Jung I, Yoo YJ. Cytosolic amyloid-[beta] peptide 42 escaping from degradation induces cell death. Biochem. Biophys. Res. Commun. 2006;344:471
  16. Leonardi A, Vito P, Mauro C, Pacifico F, Ulianich L, Consiglio E, et al. Endoplasmic reticulum stress causes thyroglobulin retention in this organelle and triggers activation of nuclear factor-{kappa}b via tumor necrosis factor receptor-associated factor 2. Endocrinology. 2002;143:2169–2177
  17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (Duluth). 2001;25:402–408
  18. MacEwan DJ. TNF ligands and receptors—a matter of life and death. Br. J. Pharmacol. 2002;135:855–875
  19. Mauro C, Crescenzi E, De Mattia R, Pacifico F, Mellone S, Salzano S, et al. Central role of the scaffold protein tumor necrosis factor receptor-associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 2006;281:2631–2638
  20. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem. Sci. 2003;28:91
  21. McGeer PL, McGeer EG. Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging. 2001;22:799
  22. Min W, Bradley JR, Galbraith JJ, Jones SJ, Ledgerwood EC, Pober JS. The N-terminal domains target tnf receptor-associated factor-2 to the nucleus and display transcriptional regulatory activity. J. Immunol. 1998;161:319–324
  23. Perry RT, Collins JS, Wiener H, Acton R, Go RCP. The role of TNF and its receptors in Alzheimer's disease. Neurobiol. Aging. 2001;22:873
  24. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S. Structural and functional features of eukaryotic mRNA untranslated regions. Gene. 2001;276:73
  25. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor. Cell. 1994;78:681
  26. Schmitz A, Schneider A, Kummer MP, Herzog V. Endoplasmic reticulum-localized amyloid β-peptide is degraded in the cytosol by two distinct degradation pathways. Traffic. 2004;5:89–101
  27. Sébastien F. Tau is not normally degraded by the proteasome. J. Neurosci. Res. 2005;80:400–405
  28. Shabalina S, Spiridonov N. The mammalian transcriptome and the function of non-coding DNA sequences. Genome Biol. 2004;5:105
  29. Sonenberg N. mRNA translation: influence of the 5′ and 3′ untranslated regions. Curr. Opin. Genet. Dev. 1994;4:310
  30. Sun L, Chen ZJ. The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. 2004;16:119
  31. Tzimas C, Michailidou G, Arsenakis M, Kieff E, Mosialos G, Hatzivassiliou EG. Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-[kappa]B. Cell. Signal. 2006;18:83
  32. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287:664–666
  33. Wajant H, Scheurich P. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Int. J. Biochem. Cell Biol. 2001;33:19
  34. Yang CH, Murti A, Pfeffer LM. Interferon induces NF-{kappa}B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-{kappa}B activation to promote cell survival. J. Biol. Chem. 2005;280:31530–31536

PII: S0197-4580(07)00413-7

doi: 10.1016/j.neurobiolaging.2007.10.014

Neurobiology of Aging
Volume 30, Issue 7 , Pages 1052-1060 , July 2009

Article Tools

* Image Usage & Resolution